Labeling changes for Reyataz.
D019380:Anti-HIV Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D000069446:Atazanavir Sulfate; D004347:Drug Interactions; D004348:Drug Labeling; D006801:Humans; D009842:Oligopeptides / Q000008:administration & dosage* / Q000627:therapeutic use; D011725:Pyridines / Q000008:administration & dosage* / Q000627:therapeutic use; D014481:United States; D014486:United States Food and Drug Administration
D019380:Anti-HIV Agents; D009842:Oligopeptides; D011725:Pyridines; D000069446:Atazanavir Sulfate